Listen to perspectives on how to effectively support patients diagnosed with acute lymphocytic leukemia (ALL) throughout the care journey from multidisciplinary cancer team members and a patient representative. Panelists define cohesive communication between the care team and the patient, describe elements required to deliver compassionate care and introduce cost awareness, and discuss how to present treatment risk-benefit analysis.
Hear critical insights from multidisciplinary cancer team members with expertise in treating older adolescents and adults with acute lymphocytic leukemia (ALL). Using a case-based approach, these experts discuss current treatment strategies for Ph(+) and Ph(-) patients, and take a closer look at the role of minimal residual disease (MRD) for prognosis and treatment selection. Special attention is paid to identification and management of cytokine release syndrome (CRS), along with pertinent drug-drug interactions when using Bcr-Abl tyrosine kinase inhibitors (TKIs) as part of combination treatment.